Hydrocortisone in Severe Community-Acquired Pneumonia | New …
Mar 21, 2023 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality. …
The Emerging Threat of H5N1 to Human Health | New England …
Dec 31, 2024 · Against this background, more humans have come into contact with HPAI A(H5N1). Investigators now report in the Journal a series of human cases from the United …
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
Dec 11, 2024 · In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or …
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
Feb 7, 2024 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne …
Diagnostic Criteria for Nonviable Pregnancy Early in the First ...
Oct 10, 2013 · Determining the viability of a pregnancy is a major challenge, especially with a pregnancy of unknown location. This review provides specific guidance, including stringent …
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ...
Jun 14, 2024 · New England Journal of Medicine. Volume 391 • Number 3 • July 18 ... VIC (B.C.V.C), and the Department of Neurology, University of New South Wales South Western …
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe …
Oct 28, 2024 · During the entire follow-up, new-onset atrial fibrillation occurred in 50 patients (13.0%) in the TAVR group and in 48 patients (12.4%) in the clinical surveillance group; death …
Ponsegromab for the Treatment of Cancer Cachexia | New …
Sep 14, 2024 · In this phase 2, randomized, double-blind, 12-week trial, we assigned patients with cancer cachexia and an elevated serum GDF-15 level (≥1500 pg per milliliter) in a 1:1:1:1 ratio …
Dapagliflozin in Patients with Chronic Kidney Disease | New …
Sep 24, 2020 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, …
Pembrolizumab plus Chemotherapy in Advanced Endometrial …
Mar 27, 2023 · In this double-blind, placebo-controlled, randomized, phase 3 trial, we assigned 816 patients with measurable disease (stage III or IVA) or stage IVB or recurrent endometrial …